Archives

by in
Entry Author Date Location
Epizyme Tacks On Extra $8M Financing For Drugs that Turn Genes On or Off 12/08/09 Boston
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic 08/26/09 Boston
Seattle Genetics Snags Milestone 08/10/09 Seattle
U.S. Venture Funding Plummets (Yada Yada), But New England Less So—Region’s Top 10 Deals of Q1 04/20/09 Boston
Trubion Wins Patent Dispute With Genentech, Biogen Idec 09/11/08 Seattle
Seattle Genetics Gunning for the Market With “Empowered Antibody” For Cancer 06/14/08 Seattle
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process 06/05/08 Boston
Biogen Idec-Icahn Story Likely Far From Over; History Says the Activist Investor Will Act Again 12/18/07 Boston
Biogen Idec on the Block; Icahn’s Interest in Buying the Firm Confirmed 10/12/07 Boston
Carl Icahn: Biogen Idec Marriage Broker? 08/27/07 Boston
Page 2 of 2 « previous page